Crizanlizumab (anti-P-selectin)
(Synonyms:立赞利珠单抗)
目录号 : KM37592
CAS No. : 1690318-25-2
Crizanlizumab (anti-P-selectin) 是一种抗 P-选择素单克隆抗体。Crizanlizumab 可与 P-选择素结合,并阻断其与 P-选择素糖蛋白配体1 (PSGL-1) 的相互作用。Crizanlizumab 可预防血管闭塞性危象 (VOC),并可用于镰状细胞病的研究。
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 生物活性 |
Crizanlizumab (anti-P-selectin) is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease.
|
| 分子量 |
146.21 kDa
|
| CAS号 |
1690318-25-2
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|